Quick Takeaways
- Avraham Gabay has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,555,847.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Avraham Gabay
- Location
- Jerusalem, Israel
- Summary
- The estimated net worth of Avraham Gabay is at least $2,555,847 dollars as of 18 Mar 2026. Avraham Gabay is the Chief Financial Officer of ORAMED PHARMACEUTICALS INC. and owns shares of ORAMED PHARMACEUTICALS INC. (ORMP) stock worth about $2.56M.
- Signature
- /s/ Avraham Gabay
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Avraham Gabay and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: ORAMED PHARMACEUTICALS INC. ($2,555,847).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Avraham Gabay
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | Chief Financial Officer | $2,555,847 | 17 Mar 2026 | ||
| PHGE | BiomX Inc. | Interim CFO | 06 Dec 2023 |
Insider Transactions Reported by Avraham Gabay:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.